Litcius/Paper detail

Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study

Marco Bandini, Filippo Pederzoli, Russell W. Madison, Alberto Briganti, Jeffrey S. Ross, Günter Niegisch, Evan Y. Yu, Aristotelis Bamias, Neeraj Agarwal, Srikala S. Sridhar, Jonathan E. Rosenberg, Joaquim Bellmunt, Sumanta K. Pal, Matthew D. Galsky, Roberta Lucianò, Andrea Gallina, Andrea Salonia, Francesco Montorsi, Siraj M. Ali, Jon Chung, Andrea Necchi

2020Clinical Genitourinary Cancer25 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCystectomyBladder cancerHazard ratioOncologyInternal medicineOdds ratioProportional hazards modelChemotherapyCancerAdenocarcinomaNeoadjuvant therapyUrologyPopulationGastroenterologyConfidence intervalEnvironmental healthBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesEsophageal Cancer Research and Treatment
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study | Litcius